These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 10872202)

  • 21. Expression analysis of biosynthetic pathway genes vis-à-vis podophyllotoxin content in Podophyllum hexandrum Royle.
    Kumar P; Pal T; Sharma N; Kumar V; Sood H; Chauhan RS
    Protoplasma; 2015 Sep; 252(5):1253-62. PubMed ID: 25586110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Podophyllotoxin: distribution, sources, applications and new cytotoxic derivatives.
    Gordaliza M; García PA; del Corral JM; Castro MA; Gómez-Zurita MA
    Toxicon; 2004 Sep; 44(4):441-59. PubMed ID: 15302526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequency and timing of leaf removal affect growth and podophyllotoxin content of Podophyllum peltatum in full sun.
    Cushman KE; Moraes RM; Gerard PD; Bedir E; Silva B; Khan IA
    Planta Med; 2006 Jul; 72(9):824-9. PubMed ID: 16791769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro propagation of Podophyllum peltatum.
    Moraes-Cerdeira RM; Burandt CL; Bastos JK; Nanayakkara NP; McChesney JD
    Planta Med; 1998 Feb; 64(1):42-5. PubMed ID: 17253216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis, and biological evaluation of novel spin-labeled derivatives of podophyllotoxin as potential antineoplastic agents. Part XII.
    Yang L; Liu YQ; Tan H; Li WG; Tian X
    Nat Prod Res; 2007 Sep; 21(11):998-1008. PubMed ID: 17691049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and characterization of Podophyllum emodi by API-LC/MS/MS.
    Wong SK; Tsui SK; Kwan SY; Su XL; Lin RC
    J Mass Spectrom; 2000 Nov; 35(11):1246-51. PubMed ID: 11114081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent developments towards podophyllotoxin congeners as potential apoptosis inducers.
    Kamal A; Hussaini SM; Malik MS
    Anticancer Agents Med Chem; 2015; 15(5):565-74. PubMed ID: 25469512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deoxypodophyllotoxin: a promising therapeutic agent from herbal medicine.
    Khaled M; Jiang ZZ; Zhang LY
    J Ethnopharmacol; 2013 Aug; 149(1):24-34. PubMed ID: 23792585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of biotechnology in the production of the anticancer compound podophyllotoxin.
    Lata H; Mizuno CS; Moraes RM
    Methods Mol Biol; 2009; 547():387-402. PubMed ID: 19521861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Podophyllotoxin derivatives as an excellent anticancer aspirant for future chemotherapy: A key current imminent needs.
    Zhang X; Rakesh KP; Shantharam CS; Manukumar HM; Asiri AM; Marwani HM; Qin HL
    Bioorg Med Chem; 2018 Jan; 26(2):340-355. PubMed ID: 29269253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SAR analysis and biological studies of synthesized podophyllum derivates obtained by N linkage modification at C-4 position.
    Wang H; Tang L; Tang Y; Yuan Z
    Bioorg Med Chem; 2014 Nov; 22(21):6183-92. PubMed ID: 25282651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two new podophyllotoxin glucosides from Sinopodophyllum emodi (Wall.) Ying.
    Zhao C; Huang J; Nagatsu A; Ogihara Y
    Chem Pharm Bull (Tokyo); 2001 Jun; 49(6):773-5. PubMed ID: 11411537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent progress on C-4-modified podophyllotoxin analogs as potent antitumor agents.
    Liu YQ; Tian J; Qian K; Zhao XB; Morris-Natschke SL; Yang L; Nan X; Tian X; Lee KH
    Med Res Rev; 2015 Jan; 35(1):1-62. PubMed ID: 24827545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Three new cytotoxic aryltetralin lignans from Sinopodophyllum emodi.
    Sun YJ; Li ZL; Chen H; Liu XQ; Zhou W; Hua HM
    Bioorg Med Chem Lett; 2011 Jun; 21(12):3794-7. PubMed ID: 21570846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biological evaluation of podophyllotoxin derivatives as selective antitumor agents.
    Wu GR; Xu B; Yang YQ; Zhang XY; Fang K; Ma T; Wang H; Xue NN; Chen M; Guo WB; Jia XH; Wang PL; Lei HM
    Eur J Med Chem; 2018 Jul; 155():183-196. PubMed ID: 29886322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C-H bond arylation in the synthesis of aryltetralin lignans: a short total synthesis of podophyllotoxin.
    Ting CP; Maimone TJ
    Angew Chem Int Ed Engl; 2014 Mar; 53(12):3115-9. PubMed ID: 24519950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and antitumor activity of spin labeled derivatives of podophyllotoxin.
    Tian X; Wang YG; Yang MG; Chen YZ
    Life Sci; 1997; 60(8):511-7. PubMed ID: 9042385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biotechnological interventions for harnessing podophyllotoxin from plant and fungal species: current status, challenges, and opportunities for its commercialization.
    Kumari A; Singh D; Kumar S
    Crit Rev Biotechnol; 2017 Sep; 37(6):739-753. PubMed ID: 27644897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Next generation sequencing in predicting gene function in podophyllotoxin biosynthesis.
    Marques JV; Kim KW; Lee C; Costa MA; May GD; Crow JA; Davin LB; Lewis NG
    J Biol Chem; 2013 Jan; 288(1):466-79. PubMed ID: 23161544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Podophyllotoxin: History, Recent Advances and Future Prospects.
    Shah Z; Gohar UF; Jamshed I; Mushtaq A; Mukhtar H; Zia-Ui-Haq M; Toma SI; Manea R; Moga M; Popovici B
    Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33921719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.